Ubs Group Ag Ampio Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.08 - $21.0 $2,097 - $550,704	26,224 Added 57.48%	71,844 $4,000
Q2 2022 Aug 10, 2022	BUY	$0.16 - $0.47 $6,499 - $19,090	40,619 Added 812.22%	45,620 $8,000
Q1 2022 May 16, 2022	SELL	$0.42 - $0.62 $34,572 - $51,035	-82,316 Reduced 94.27%	5,001 $2,000
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.71 $45,979 - $140,401	82,106 Added 1575.63%	87,317 $50,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.8 $5,095 - $7,579	4,211 Added 421.1%	5,211 $8,000
Q1 2020 May 01, 2020	SELL	$0.36 - $0.74 $12,368 - $25,424	-34,357 Reduced 97.17%	1,000 $0
Q4 2019 Feb 14, 2020	SELL	$0.35 - $0.58 $3,182 - $5,273	-9,092 Reduced 20.45%	35,357 $21,000
Q3 2019 Nov 14, 2019	BUY	$0.38 - $0.52 $16,510 - $22,593	43,449 Added 4344.9%	44,449 $22,000
Q2 2019 Aug 14, 2019	BUY	$0.39 - $0.7 $390 - $700	1,000 New	1,000 $0
Q1 2019 May 14, 2019	SELL	$0.43 - $0.68 $47,824 - $75,628	-111,219 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.39 - $0.7 $26,618 - $47,777	68,253 Added 158.85%	111,219 $44,000
Q3 2018 Nov 14, 2018	BUY	$0.44 - $3.02 $17,941 - $123,140	40,775 Added 1861.02%	42,966 $22,000
Q2 2018 Aug 14, 2018	SELL	$1.66 - $3.82 $2,504 - $5,764	-1,509 Reduced 40.78%	2,191 $5,000
Q4 2017 Feb 14, 2018	SELL	$0.68 - $4.19 $1,442 - $8,886	-2,121 Reduced 36.44%	3,700 $15,000
Q3 2017 Nov 14, 2017	BUY	$0.38 - $0.66 $794 - $1,380	2,091 Added 56.06%	5,821 $3,000
Q2 2017 Aug 14, 2017	SELL	N/A	-1,016 Reduced 21.41%	3,730 $2,000
Q1 2017 Nov 14, 2017	BUY	N/A	4,746	4,746 $4,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.